Page last updated: 2024-08-21

1,2,4-triazole and Extravascular Hemolysis

1,2,4-triazole has been researched along with Extravascular Hemolysis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Anjum, MN; Irfan, A; Kotwica-Mojzych, K; Mansha, A; Mojzych, M; Rasul, A; Shahzadi, I; Tüzün, B; Zahoor, AF1
Aswathanarayanappa, C; Bheemappa, E; Bodke, YD; Krishnegowda, PS; Ningegowda, R; Venkata, SP1

Other Studies

2 other study(ies) available for 1,2,4-triazole and Extravascular Hemolysis

ArticleYear
Repositioning of acefylline as anti-cancer drug: Synthesis, anticancer and computational studies of azomethines derived from acefylline tethered 4-amino-3-mercapto-1,2,4-triazole.
    PloS one, 2022, Volume: 17, Issue:12

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Repositioning; Drug Screening Assays, Antitumor; Hemolysis; Humans; Liver Neoplasms; Molecular Structure; Structure-Activity Relationship; Triazoles

2022
Synthesis and evaluation of antioxidant properties of novel 1,2,4-triazole-based schiff base heterocycles.
    Archiv der Pharmazie, 2013, Volume: 346, Issue:12

    Topics: Antioxidants; Biphenyl Compounds; DNA Damage; Dose-Response Relationship, Drug; Erythrocyte Membrane; Free Radical Scavengers; Hemolysis; Humans; Lipid Peroxidation; Molecular Structure; Oxidative Stress; Phenethylamines; Picrates; Schiff Bases; Triazoles

2013